NCT03185351View on ClinicalTrials.gov

Midazolam in Supraclavicular Brachial Plexus Block

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 14, 2017

Primary Completion Date

September 1, 2018

Study Completion Date

September 1, 2018

Conditions
Forearm Surgeries
Interventions
DRUG

Bupivacaine

20 ml of 0.5% bupivacaine using supraclavicular BPB.

DRUG

Midazolam

midazolam 0.03 mg/kg dissolved in 5 ml normal saline (0.9%) using supraclavicular BPB

DRUG

Midazolam

0.03 mg/kg of midazolam by I.V. route

Trial Locations (1)

Unknown

Assiut University Hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03185351 - Midazolam in Supraclavicular Brachial Plexus Block | Biotech Hunter | Biotech Hunter